Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
(Reuters) – Merck on Wednesday agreed to acquire privately held biotech EyeBio for as much...
(Reuters) – Merck on Wednesday agreed to acquire privately held biotech EyeBio for as much...
(Reuters) – BlackRock’s iShares Bitcoin Trust has become the world’s largest fund for the original...
WASHINGTON (Reuters) – Donald Trump is considering tapping billionaire Elon Musk as a policy adviser...
(Reuters) -Activist investor Elliott Investment Management disclosed a $2.5 billion stake in analog chipmaker Texas...
(Reuters) – Verizon said on Tuesday that it added Comcast’s Peacock to its streaming subscription...
By Zaheer Kachwala (Reuters) – Nvidia’s shares rallied around 6% to hit a record high...
(Reuters) – American Airlines on Tuesday cut its second-quarter profit forecast, sending the shares of...
By Emily Chow PERTH, Australia (Reuters) – Shell expects its Australian supplies of liquefied natural...
WASHINGTON (Reuters) – U.S. Capitol Police were investigating a suspicious substance Wednesday on a street...
By Ankika Biswas and Lisa Pauline Mattackal (Reuters) -Wall Street’s main indexes were set for...